Protein CC16
PreclinicalSmall molecule
Protein CC16 is one of 3 small molecule programs targeting Acute Bronchiolitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Acute Bronchiolitis
#DrugCompanyPhaseTrials
1Singulair
OOrganon and Co
Phase 2
Singulair
AstraZenecaPreclinical
Protein CC16
UUniversity Hospital, Clermont-Ferrand
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Protein CC16. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details